West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack

Core Insights - West Pharmaceutical Services, Inc. is showcasing its leadership in drug delivery solutions at Pharmapack 2026 in Paris, highlighting the global commercial availability of the West Synchrony S1 prefillable syringe (PFS) system [1][4] Product Overview - The West Synchrony S1 PFS system includes a diverse product portfolio with options for biologics and vaccines, featuring 1 ml long and 2.25 ml staked needle options, as well as 1 ml standard staked needle and Luer lock options [3] - The system is designed for seamless interaction between components, ensuring reliable and efficient drug delivery performance [2] Market Trends - The company is closely monitoring shifts in the global drug pipeline, particularly the increasing demand for combination products and the transition of care from hospital to home, which complicates regulatory and development processes [4] - The surge of innovation in the industry underscores the timely introduction of the West Synchrony S1 PFS system [4] Company Background - West Pharmaceutical Services, Inc. is a leading provider of high-quality injectable solutions, delivering over 41 billion components and devices annually, with a workforce of over 10,000 across 50 sites [9] - In fiscal year 2024, the company generated $2.89 billion in net sales and is listed on the New York Stock Exchange [10]